Markus D. Siegelin
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cell death mechanisms and regulation 28
- Mitochondrial Function and Pathology 13
- RNA Interference and Gene Delivery 12
- Ubiquitin and proteasome pathways 12
- Protein Degradation and Inhibitors 9
- Histone Deacetylase Inhibitors Research 9
- Genetics 34
- Glioma Diagnosis and Treatment 34
- Co-authors
- Georg Karpel‐Massler (60 shared papers)Mike‐Andrew Westhoff (51 shared papers)Timo Gaiser (12 shared papers)Antje Habel (11 shared papers)Alain Borczuk (1 shared paper)Dario C. Altieri (8 shared papers)Chang Shu (18 shared papers)Marc‐Eric Halatsch (28 shared papers)
- Journals
- Oncotarget (9 papers)Neuro-Oncology (7 papers)Clinical Cancer Research (6 papers)Cells (6 papers)Scientific Reports (5 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Markus D. Siegelin
103 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 119
- Genetics 802
- Cancer Research 1.0k
- Molecular Biology 2.7k
- Oncology 786
- Cell Biology 343
Countries citing papers authored by Markus D. Siegelin
This map shows the geographic impact of Markus D. Siegelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus D. Siegelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus D. Siegelin more than expected).
Fields of papers citing papers by Markus D. Siegelin
This network shows the impact of papers produced by Markus D. Siegelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus D. Siegelin. The network helps show where Markus D. Siegelin may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus D. Siegelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 192 | |
| 2 | 2013 | 187 | |
| 3 | 2010 | 150 | |
| 4 | 2020 | 140 | |
| 5 | 2011 | 136 | |
| 6 | 2008 | 117 | |
| 7 | 2010 | 96 | |
| 8 | 2010 | 95 | |
| 9 | 2015 | 93 | |
| 10 | 2017 | 87 | |
| 11 | 2010 | 81 | |
| 12 | 2022 | 77 | |
| 13 | 2021 | 76 | |
| 14 | 2008 | 76 | |
| 15 | 2009 | 74 | |
| 16 | 2014 | 72 | |
| 17 | 2019 | 71 | |
| 18 | 2009 | 69 | |
| 19 | 2013 | 69 | |
| 20 | 2010 | 65 |
About Markus D. Siegelin
Markus D. Siegelin is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Cell Biology, having authored 109 papers that have together received 4.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (34 papers), Cell death mechanisms and regulation (28 papers), Cancer, Hypoxia, and Metabolism (20 papers), Mitochondrial Function and Pathology (13 papers), RNA Interference and Gene Delivery (12 papers), Ubiquitin and proteasome pathways (12 papers), Protein Degradation and Inhibitors (9 papers) and Histone Deacetylase Inhibitors Research (9 papers). The work is most often cited by research in Genetics (802 citations), Cancer Research (1.0k citations), Molecular Biology (2.7k citations), Oncology (786 citations) and Cell Biology (343 citations). Markus D. Siegelin has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Georg Karpel‐Massler, Mike‐Andrew Westhoff, Timo Gaiser, Antje Habel, Alain Borczuk, Dario C. Altieri, Chang Shu, Marc‐Eric Halatsch, Peter Canoll and Jeffrey N. Bruce. Their work appears in journals such as Oncotarget, Neuro-Oncology, Clinical Cancer Research, Cells and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.